BAUSCH HEALTH COMPANIES INC.

(BHC)
  Report
Delayed Nyse  -  05/19 04:00:02 pm EDT
10.15 USD   +2.01%
09:54aSalix Pharmaceuticals To Share New Data At Digestive Disease Week 2022
AQ
05/18Bausch Health Says Salix Pharmaceuticals To Share New Data
MT
05/16Moody's Cuts Bausch Health's Senior Secured Ratings
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Bausch Health Companies Inc.
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.

Number of employees : 19 100 people.
Sales per Business
20202021Delta
Bausch + Lomb/International4 408.0054.9%3 765.0044.6% -14.59%
Salix1 904.0023.7%2 074.0024.6% +8.93%
International Rx--1 166.0013.8%-
Diversified Products1 162.0014.5%865.0010.3% -25.56%
Ortho Dermatologics553.006.9%564.006.7% +1.99%
USD in Million
Sales per region
20202021Delta
United States and Puerto Rico4 791.0059.7%4 887.0057.9% +2%
Other1 008.0012.6%986.0011.7% -2.18%
China341.004.2%490.005.8% +43.7%
Canada331.004.1%343.004.1% +3.63%
Poland238.003%280.003.3% +17.65%
Mexico225.002.8%256.003% +13.78%
Japan226.002.8%230.002.7% +1.77%
France179.002.2%208.002.5% +16.2%
Russia137.001.7%160.001.9% +16.79%
Egypt243.003%156.001.8% -35.8%
Germany144.001.8%154.001.8% +6.94%
United Kingdom86.001.1%116.001.4% +34.88%
Spain78.001%88.001% +12.82%
Italy--80.000.9%-
USD in Million
Managers
Name Title Age Since
Joseph Papa Chairman & Chief Executive Officer 65 2016
Thomas Appio President & Co-Head-Bausch Lomb International - -
Sam Eldessouky CFO, Chief Accounting Officer, SVP & Controller 48 2021
Tage Ramakrishna Chief Medical Officer, President-R&D 46 2011
Arthur J. Shannon Head-Investor Relations, Communications & SVP - 2017
William Norman Woodfield Treasurer & Vice President 45 2018
Stacey Williams Vice President-Marketing - 2017
Christina Maria Ackermann Head-Commercial Operations 56 2020
Louis W. Yu, Dr. Chief Quality Officer 70 2016
Dennis Asharin Chief Global Manufacturing & Supply Chain Officer - 2007
Members of the board
Name Title Age Since
Joseph Papa Chairman & Chief Executive Officer 65 2016
Robert N. Power Independent Director 64 2008
Thomas Warren Ross Lead Independent Director 70 2016
Argeris N. Karabelas, Dr. Independent Director 68 2016
Russel Robertson Independent Director 73 2016
Amy B. Wechsler, Dr. Independent Director 51 2016
Sarah B. Kavanagh Independent Director 64 2016
Richard de Schutter Independent Director 80 2017
John Alfred Paulson Independent Director 65 2017
Andrew C. von Eschenbach, Dr. Independent Director 79 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 361,479,708 346,274,683 95.8% 0 0.0% 95.8%
Shareholders
NameEquities%
Icahn Associates Holding LLC 34,721,118 9.65%
Paulson & Co., Inc. 25,839,035 7.18%
Nomura Securities Co., Ltd. (Private Banking) 18,990,079 5.28%
Pershing Square Capital Management LP 18,114,432 5.04%
ValueAct Capital Management LP 15,616,761 4.34%
Glenview Capital Management LLC 12,502,147 3.48%
Laurion Capital Management LP 9,689,643 2.69%
PointState Capital LP 8,515,600 2.37%
Brahman Capital Corp. 8,117,753 2.26%
Viking Global Investors LP 7,793,397 2.17%
Company contact information
Bausch Health Cos., Inc.
2150 St. Elzéar Boulevard West
Laval, QC H7L 4A8

Phone : +1.514.744.6792
Fax : +1.514.744.6272
Web : http://www.bauschhealth.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Bausch Health Companies Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
BAUSCH HEALTH COMPANIES INC.-63.96%3 597
JOHNSON & JOHNSON2.59%461 811
PFIZER, INC.-14.65%282 789
ABBVIE INC.12.58%269 361
ELI LILLY AND COMPANY6.87%265 718
ROCHE HOLDING AG-15.26%264 329
NOVO NORDISK A/S1.07%238 091
MERCK & CO., INC.20.17%232 903
ASTRAZENECA PLC18.05%196 890
NOVARTIS AG8.37%191 223
BRISTOL-MYERS SQUIBB COMPANY23.53%163 981
SANOFI13.93%132 243
AMGEN INC.8.44%130 323
GLAXOSMITHKLINE PLC10.18%111 134
BAYER AG35.74%65 777
DAIICHI SANKYO CO., LTD.13.68%49 715
CHUGAI PHARMACEUTICAL CO., LTD-2.84%46 551
TAKEDA PHARMACEUTICAL COMPANY LIMITED17.63%44 429
ASTELLAS PHARMA INC.6.50%27 985
JIANGSU HENGRUI MEDICINE CO., LTD.-42.06%27 750
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-32.11%26 513